NPS Pharmaceuticals, Inc. Press Releases

NPS Pharmaceuticals President and CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst & Young Entrepreneur of the Year® 2013
05/16/2013 8:00AM - Business Wire

NPS Pharmaceuticals Recognized by National Organization for Rare Disorders for Gattex® as an Innovative Treatment for Patients with Short Bowel Syndrome
05/15/2013 8:15AM - Business Wire

NPS Pharmaceuticals Reports First Quarter 2013 Financial Results
05/09/2013 8:00AM - Business Wire

NPS Pharmaceuticals to Report First Quarter 2013 Financial Results
05/01/2013 8:00AM - Business Wire

NPS Pharmaceuticals Among 100 Best Places to Work in New Jersey for Second Consecutive Year
04/26/2013 8:00AM - Business Wire

NPS Pharmaceuticals to Present at Needham Healthcare Conference
04/22/2013 8:10AM - Business Wire

NPS Pharmaceuticals and Takeda Revise Agreements and NPS Re-Gains Full Worldwide Rights to Teduglutide and Recombinant Human Parathyroid Hormone 1-84
03/19/2013 2:00AM - Business Wire

Upcoming Results from Clinical Trials - Research Report on Gilead Sciences, Celgene Corporation, Sinovac Biotech, NPS Pharmaceuticals and ZIOPHARM Oncology
03/18/2013 8:00AM - PR Newswire

New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry's Growth in 2012
03/15/2013 8:20AM - Market Wire

NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference
03/05/2013 8:10AM - Business Wire

NPS Pharmaceuticals Observes Rare Disease Day 2013 and Celebrates 30th Anniversary of National Organization for Rare Disorders
02/28/2013 8:00AM - Business Wire

NPS Pharmaceuticals Reports 2012 Financial Results and 2013 Guidance
02/21/2013 4:01PM - Business Wire

NPS Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
02/19/2013 4:10PM - Business Wire

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
02/18/2013 8:20AM - Market Wire